SCHEMBL24600583

SCHEMBL24600583

COC(=O)c1cc(N)ccc1OCCN(C)CCc1ccc(N)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 5/20 0.46
ALDH1A1 P00352 3/20 0.44
HTT P42858 1/20 0.44
KDM4E B2RXH2 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 3/20 0.41
GAA P10253 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP3A4 P08684 1/20 0.41
CACNA1F O60840 1/20 0.40
CHRM2 P08172 1/20 0.40
ACHE P22303 1/20 0.40
AGTR1 P30556 1/20 0.40
DRD3 P35462 1/20 0.40
CACNA1D Q01668 1/20 0.40
CACNA1S Q13698 1/20 0.40
CACNA1C Q13936 1/20 0.40
BLM P54132 1/20 0.40
PMP22 Q01453 1/20 0.40
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601338 0.85 KCNH2 (0.42) KCNH2CYP1A2CYP2D6CYP3A4CACNA1F
SCHEMBL26239278 0.80 KCNH2 (0.39) KCNH2ALDH1A1KDM4ECYP1A2CYP2D6
SCHEMBL26239253 0.80 KCNH2 (0.61) KCNH2ALDH1A1HTTBLMMAPT
SCHEMBL26240045 0.79 KCNH2 (0.64) KCNH2ALDH1A1HTTSMN1; SMN2CYP1A2
SCHEMBL5102530 0.79 CYP2D6 (0.59) KCNH2ALDH1A1HTTKDM4ESMN1; SMN2
SCHEMBL10726453 0.79 LMNA (0.50) KCNH2ALDH1A1HTTKDM4ECYP3A4
SCHEMBL28092143 0.77 MAPT (0.55) KCNH2ALDH1A1HTTKDM4ESMN1; SMN2
SCHEMBL26640241 0.77 GAA (0.51) ALDH1A1HTTKDM4ESMN1; SMN2CYP1A2
SCHEMBL26239252 0.77 KCNH2 (0.59) KCNH2ALDH1A1HTTSMN1; SMN2CYP1A2
SCHEMBL12121313 0.76 HTR2A (0.52) ALDH1A1HTTKDM4ESMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025846-A1 ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS ACAD PHARMACEUTICALS INC (US) 2024-01-25 US disclosed
US-20240025846-A1 ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS ACAD PHARMACEUTICALS INC (US) 2024-01-25 US disclosed
US-11731938-B2 Ultra short acting anti-arrhythmic agents ACADEMIC PHARMACEUTICALS INC (US) 2023-08-22 US disclosed
US-11731938-B2 Ultra short acting anti-arrhythmic agents ACADEMIC PHARMACEUTICALS INC (US) 2023-08-22 US disclosed
US-20220213032-A1 ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS ACADEMIC PHARMACEUTICALS INC 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213032-A1 ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS CACNA1G, SCN5A, CACNA1F KCNH2 51/4885ALDH1A1 1515/4885HTT 2621/4885
US-11731938-B2 Ultra short acting anti-arrhythmic agents CACNA1G, SCN5A, CACNA1F KCNH2 51/4885ALDH1A1 1515/4885HTT 2621/4885
US-20240025846-A1 ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS CACNA1G, SCN5A, CACNA1F KCNH2 51/4885ALDH1A1 1515/4885HTT 2621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.